Test subjects were randomly assigned to one of nine experimental treatments including once-weekly semaglutide in doses of 0.1, 0.2, 0.4, or 0.8 mg, once-weekly semaglutide with dose escalation (E) (0.8 or 1.6 mg E), once-daily active control (1.2 or 1.8 mg), or once-weekly placebo
But robust, high-quality evidence for durable cosmetic skin-lightening from IV glutathione is lacking, and the FDA has not approved glutathione for skin lightening
Looking for additional information
Novo Nordisk, Boehringer Ingelheim, Hims & Hers, Novartis, Ro, and Lilly all plan to air spots during or before the Super Bowl on Sunday, alongside wellness and lifestyle brands like Oikos and Liquid IV
B12 deficiency is quite common in both the US and UK, affecting around 6% of people aged under 60, and nearly 20% of those 60 and over